Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders
Sentiment Mix
Geography
Expert Signals
Fox News - Latest Headlines
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Neurologists warn that GLP-1 weight-loss drugs like semaglutide may accelerate ALS progression by triggering dangerous rapid weight loss in patients.
Supported by 1 story
Related Events
For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough
Uncategorized • 7/16/2026
Ontario Funds Repetitive Transcranial Magnetic Stimulation - Medscape
Uncategorized • 7/16/2026
FDA approves new kind of cholesterol pill - NBC News
Uncategorized • 7/16/2026
Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease - ABC News - Breaking News, Latest News and Videos
Research • 7/16/2026
Ontario's Hillside Festival has sold out for the 1st time in 14 years thanks, in part, to Angine de Poitrine - CBC
Uncategorized • 7/16/2026